Why Johnson & Johnson is the 'golden child' of transformative AI use cases

Johnson & Johnson raised its 2026 sales forecast, but its stock traded lower. Defiance ETFs CIO Sylvia Jablonski highlighted the company's use of AI as a key driver for its long-term growth in pharmaceuticals and biotech.

Johnson & Johnson JNJ https://finance.yahoo.com/quote/JNJ/ stock is trading lower even after the company raised its 2026 sales forecast. Defiance ETFs chief investment officer Sylvia Jablonski and Yahoo Finance's Julie Hyman discuss the importance of AI for Johnson & Johnson, pharmaceuticals, and biotech.